I am med student doing mbbs in 4th year .. their is my pediatrics practical exam tommarow in viva their are drugs for spotting .. so I will tell u drug and you tell me what are it indication , dose, and diseases , in short
Neostigmin
| Use | Details |
|---|---|
| Myasthenia Gravis | Main use - both diagnosis and treatment |
| Reversal of NMB | Reverses non-depolarizing neuromuscular blockers (e.g. vecuronium, pancuronium) post-op |
| Ogilvie's syndrome | Acute colonic pseudo-obstruction |
| Snake bite (neurotoxic) | Cobra & Russell's viper - reverses neuroparalysis |
| Urinary retention | Post-op non-obstructive urinary retention |
| Indication | Route | Dose |
|---|---|---|
| MG Diagnosis | IM | 0.025-0.04 mg/kg x 1 (give atropine before!) |
| MG Treatment | IM/IV/SC | 0.01-0.04 mg/kg/dose Q2-4 hr PRN |
| NMB Reversal | IV | 0.03-0.07 mg/kg/dose (max 5 mg) |
| Snake bite | IM | 0.04 mg/kg (with atropine 0.01 mg/kg) |
Paracetamol
| Indication | Notes |
|---|---|
| Fever | Drug of choice for fever in children |
| Mild-moderate pain | Headache, post-vaccination pain, teething |
| Patent Ductus Arteriosus (PDA) | When NSAIDs are contraindicated or failed |
| Post-op analgesia | IV form used |
| Age | Dose |
|---|---|
| 0-3 months | 40 mg |
| 4-11 months | 80 mg |
| 1-2 years | 120 mg |
| 2-3 years | 160 mg |
| 4-5 years | 240 mg |
| 6-8 years | 320-325 mg |
| 9-10 years | 325-400 mg |
| 11 years | 480-500 mg |
Adrenaline bitrate
| Indication | Key Point |
|---|---|
| Anaphylaxis | Drug of CHOICE - first line |
| Cardiac arrest / Asystole / Pulseless arrest | PALS algorithm |
| Bronchospasm / Severe asthma | Bronchodilation via β2 |
| Croup (nebulized) | Racemic or L-epinephrine |
| Bradycardia | Unresponsive to atropine |
| Septic/cardiogenic shock | IV infusion |
| Local anesthetic adjunct | Prolongs duration, reduces bleeding |
Adrenaline bitrate
| Use | Dose |
|---|---|
| Anaphylaxis (IM) | 0.01 mg/kg, max 0.3-0.5 mg |
| Cardiac arrest (IV/IO) | 0.01 mg/kg of 1:10,000 |
| ET tube | 0.1 mg/kg of 1:1,000 |
| IV infusion | 0.1-1 mcg/kg/min |
Atropin
| Indication | Notes |
|---|---|
| Bradycardia | Symptomatic sinus bradycardia - first line |
| Cardiac arrest / CPR | Used in PALS algorithm |
| Organophosphate / Carbamate poisoning | Antidote for nerve agent/insecticide poisoning |
| Pre-intubation / Pre-anesthesia | Reduces secretions, prevents vagal bradycardia |
| Bronchospasm | Nebulized (adjunct) |
| With Neostigmine | Blocks muscarinic side effects of neostigmine |
| Uveitis (ophthalmic) | Cycloplegia / mydriasis |
| Anticholinergic antidote | Given before physostigmine |
| Age/Weight | Dose |
|---|---|
| <6 months (<7 kg) | 0.25 mg |
| 6 mo-4 yr (7-18 kg) | 0.5 mg |
| 4-10 yr (18-41 kg) | 1 mg |
| >10 yr & adult (>41 kg) | 2 mg |
Ondansetron
| Indication | Notes |
|---|---|
| Chemotherapy-induced nausea/vomiting (CINV) | Main indication |
| Post-operative nausea/vomiting (PONV) | Pre-anesthesia |
| Acute gastroenteritis (AGE) | Vomiting in children |
| Radiation-induced nausea/vomiting | Before radiotherapy |
| Weight | Dose |
|---|---|
| 8-15 kg | 2 mg x 1 |
| >15-30 kg | 4 mg x 1 |
| >30 kg | 8 mg x 1 |
| Age | Dose |
|---|---|
| 4-11 yr | 4 mg TID |
| >11 yr / adult | 8 mg TID |
Dopamine
| Indication | Notes |
|---|---|
| Cardiogenic shock | Improves cardiac output |
| Septic shock | Vasopressor support |
| Hemodynamically unstable bradycardia | Increases HR |
| Acute renal failure / low renal perfusion | Low dose (controversial now) |
| Post-cardiac surgery hypotension | Inotropic support |
| Dose | Receptors | Effect |
|---|---|---|
| Low: 2-5 mcg/kg/min | Dopaminergic (D1) | ↑ Renal blood flow, renal vasodilation, ↑ urine output; minimal effect on HR/CO |
| Intermediate: 5-15 mcg/kg/min | β1 | ↑ Heart rate, ↑ contractility, ↑ cardiac output |
| High: >15 mcg/kg/min | α1 | Vasoconstriction, ↓ renal perfusion, ↑ BP |
"DoBeta Alpha" - as dose goes up, receptors added: D → β1 → α1
Vit k3
⚠️ Vit K3 = Menadione (synthetic, water-soluble) - largely obsolete/avoided in pediatrics due to toxicity. What is actually used clinically is Vitamin K1 = Phytonadione (natural, fat-soluble). Your viva will almost certainly be about K1. Both covered below.
| Indication | Notes |
|---|---|
| Hemorrhagic Disease of Newborn (HDN) | = Vitamin K Deficiency Bleeding (VKDB) - most important pediatric use |
| Warfarin overdose/reversal | Antidote |
| Vitamin K deficiency | Liver disease, cholestasis, malabsorption |
| Anticoagulant reversal | Pre-surgery |
| Birth weight | Dose |
|---|---|
| <1 kg | 0.5 mg/kg x 1 |
| 1-1.5 kg | 0.5 mg x 1 |
| >1.5 kg (normal neonate) | 1 mg IM x 1 |
Phenylamine
Quick note: "Phenylamine" most likely refers to Phentolamine - the alpha-blocker used in pediatrics. If you meant Phenylephrine (alpha-1 agonist), let me know and I'll do that one too!
| Indication | Notes |
|---|---|
| Pheochromocytoma | Pre-op BP control + diagnosis (Regitine test) |
| Hypertensive crisis | Due to catecholamine excess (MAO inhibitor crisis, cocaine, clonidine withdrawal) |
| Vasopressor extravasation | Dopamine, norepinephrine, adrenaline skin necrosis antidote |
| Erectile dysfunction | Intracavernosal (with papaverine) |
| Feature | Phentolamine | Phenoxybenzamine |
|---|---|---|
| Type | Reversible | Irreversible |
| Route | IV | Oral |
| Duration | Short (4 hr) | Long (24-48 hr) |
| Use | Acute crisis | Pre-op prep |
Dexamethasone
| Indication | Notes |
|---|---|
| Croup (Laryngotracheobronchitis) | Drug of choice - single dose |
| Asthma exacerbation | Short course |
| Cerebral edema | Tumour, meningitis |
| Airway edema / Post-extubation stridor | Pre/post-extubation |
| Bacterial meningitis | Reduces neurological sequelae |
| Antiemetic (chemo-induced) | With ondansetron |
| Adrenal insufficiency | Stress dosing |
| Ophthalmic inflammation | Eye drops |
| Anti-inflammatory | General use |
| Indication | Dose | Route | Frequency |
|---|---|---|---|
| Croup | 0.6 mg/kg x 1 (max 16 mg) | PO/IV/IM | Single dose |
| Asthma exacerbation | 0.6 mg/kg/dose (max 16 mg) | PO/IV/IM | Q24 hr x 1-2 doses |
| Airway edema/extubation | 0.5 mg/kg/dose (max 10 mg) | IV/IM/PO | Q6 hr x 6 doses (start 6-12 hr before extubation) |
| Cerebral edema - Loading | 1-2 mg/kg x 1 | IV/IM | Once |
| Cerebral edema - Maintenance | 1-2 mg/kg/24 hr (max 16 mg/24 hr) | IV/IM | ÷ Q4-6 hr |
| Anti-inflammatory | 0.08-0.3 mg/kg/24 hr | PO/IV/IM | ÷ Q6-12 hr |
| Antiemetic (chemo) | 10 mg/m²/dose (max 20 mg) initial, then 5 mg/m² Q6 hr | IV | - |
Artisunate
| Indication | Notes |
|---|---|
| Severe / Complicated Falciparum Malaria | Drug of CHOICE - IV artesunate is first line |
| Uncomplicated Falciparum Malaria | Oral - part of ACT (Artemisinin Combination Therapy) |
| Malaria unable to tolerate oral drugs | IV route |
| Multi-drug resistant malaria | Effective where chloroquine/quinine fail |
Metronidazole
| Indication | Notes |
|---|---|
| Amoebiasis (E. histolytica) | Intestinal + hepatic amoebic abscess |
| Giardiasis (G. lamblia) | Drug of choice |
| Trichomoniasis | Treat sexual contacts too |
| Anaerobic bacterial infections | Intra-abdominal, pelvic, brain abscess |
| C. difficile infection | Mild-moderate (vancomycin for severe) |
| H. pylori | Part of triple therapy |
| Bacterial vaginosis | Oral/vaginal |
| Indication | Dose | Duration |
|---|---|---|
| Amoebiasis | 35-50 mg/kg/24 hr ÷ Q8 hr PO (max 750 mg/dose) | 10 days |
| Giardiasis | 15-30 mg/kg/24 hr ÷ TID PO (max 750 mg/24 hr) | 5-7 days |
| Trichomoniasis (<45 kg) | 45 mg/kg/24 hr ÷ TID (max 2 g/24 hr) | 7 days |
| Anaerobic infection (child PO) | 30-50 mg/kg/24 hr ÷ Q8 hr (max 2250 mg/24 hr) | - |
| Anaerobic infection (child IV) | 22.5-40 mg/kg/24 hr ÷ Q6-8 hr (max 4 g/24 hr) | - |
| C. difficile (child) | 30 mg/kg/24 hr ÷ Q6 hr PO | 10 days |
| H. pylori (child) | 20 mg/kg/24 hr ÷ BID PO (max 1 g/24 hr) | 10-14 days |
| PMA | Maintenance |
|---|---|
| 24-25 wk | 7.5 mg/kg Q24 hr |
| 28-33 wk | 7.5 mg/kg Q12 hr |
| 34-40 wk | 7.5 mg/kg Q8 hr |
| >40 wk | 7.5 mg/kg Q6 hr |
Urine strips
| Parameter | Normal | Abnormal Finding | Disease/Significance |
|---|---|---|---|
| pH | 4.5 - 8.0 | Acidic <4.5 | RTA (Type 1), starvation, acidosis |
| Alkaline >8.0 | UTI (urease-producing organisms), RTA Type 2 | ||
| Specific Gravity | 1.005 - 1.030 | Low (<1.005) | Diabetes insipidus, overhydration |
| High (>1.030) | Dehydration | ||
| Protein | Negative/Trace | +1 to +4 | Nephrotic syndrome, UTI, glomerulonephritis |
| Glucose | Negative | Positive | Diabetes mellitus, Fanconi syndrome |
| Ketones | Negative | Positive | DKA, starvation, vomiting |
| Blood (RBCs) | Negative | Positive | UTI, glomerulonephritis, trauma, stones |
| Nitrites | Negative | Positive | Bacterial UTI (gram-negative organisms) |
| Leukocyte Esterase | Negative | Positive | UTI, pyuria |
| Bilirubin | Negative | Positive | Obstructive jaundice, liver disease |
| Urobilinogen | Trace (0.1-1 EU) | High | Haemolytic jaundice, liver disease |
| Absent | Obstructive jaundice |
| Parameter | False Positive | False Negative |
|---|---|---|
| Protein | Alkaline urine, contamination | Dilute urine |
| Blood | Myoglobinuria, haemoglobinuria | High Vit C |
| Glucose | - | High Vit C |
| Nitrites | - | Non-nitrite-reducing organisms (Staph, Enterococcus) |
"This is a urine dipstick reagent strip used for rapid bedside urinalysis. It tests for pH, specific gravity, protein, glucose, ketones, blood, nitrites, leukocyte esterase, bilirubin and urobilinogen. It helps diagnose conditions like UTI, nephrotic syndrome, DKA and jaundice."
Cefpodoxime proxetiland potassium calvunate
| Indication | Dose | Duration |
|---|---|---|
| Acute Otitis Media (AOM) | 10 mg/kg/24 hr ÷ Q12 hr PO (max 400 mg/24 hr) | 5-10 days |
| Pharyngitis/Tonsillitis | 10 mg/kg/24 hr ÷ Q12 hr PO (max 200 mg/24 hr) | 5-10 days |
| Acute Sinusitis | 10 mg/kg/24 hr ÷ Q12 hr PO (max 400 mg/24 hr) | 10 days |
| CAP / Bronchitis (≥12 yr) | 400 mg/24 hr ÷ Q12 hr | 14 days |
| UTI (≥12 yr) | 200 mg/24 hr ÷ Q12 hr | 5-7 days |
| Indication | Notes |
|---|---|
| Acute Otitis Media (AOM) | Especially beta-lactamase-producing organisms |
| Sinusitis | First/second line |
| Pneumonia (CAP) | Community acquired |
| Tonsillitis / Pharyngitis | |
| UTI | |
| Skin & soft tissue infections | |
| Animal/human bites | Drug of CHOICE |
| Orbital cellulitis | High dose |
| Age/Weight | Dose | Frequency |
|---|---|---|
| Infant 1-<3 months | 30 mg/kg/24 hr | ÷ Q12 hr |
| Child ≥3 mo, <40 kg (standard) | 20-40 mg/kg/24 hr | ÷ Q8 hr (TID) |
| Child ≥3 mo, <40 kg (standard BID) | 25-45 mg/kg/24 hr | ÷ Q12 hr |
| High dose (>3 mo, <40 kg) | 90 mg/kg/24 hr (use ES-600) | ÷ Q8-12 hr |
| Adult | 250-500 mg Q8 hr or 875 mg Q12 hr | - |
| Feature | Cefpodoxime | Amoxicillin-Clavulanate |
|---|---|---|
| Class | 3rd gen cephalosporin | Aminopenicillin + BLI |
| Route | Oral only | Oral |
| Beta-lactamase? | Resistant (3rd gen) | Clavulanate inhibits it |
| Main use | AOM, pharyngitis, UTI | AOM, bites, pneumonia |
Levetriacetam oral solution
| Indication | Age |
|---|---|
| Partial (focal) seizures | ≥1 month |
| Myoclonic seizures (Juvenile Myoclonic Epilepsy) | ≥12 yr |
| Primary generalized tonic-clonic seizures | ≥6 yr |
| Refractory status epilepticus | All ages (IV/IO) |
| Age | Starting Dose | Target Dose |
|---|---|---|
| Infant 1-5 months | 7 mg/kg/dose BID | 21 mg/kg/dose BID |
| Infant ≥6 mo - 3 yr | 10 mg/kg/dose BID | 25 mg/kg/dose BID |
| Child 4-15 yr | 10 mg/kg/dose BID | 30 mg/kg/dose BID (max 3000 mg/24 hr) |
| ≥16 yr / Adult | 500 mg BID | max 1500 mg BID |
Increase dose by 10 mg/kg/dose BID every 2 weeks as tolerated
"This is Levetiracetam oral solution 100 mg/mL (Keppra). It is an anticonvulsant used for partial, myoclonic, and generalized tonic-clonic seizures. The dose is weight-based, starting at 10 mg/kg/dose twice daily and titrated up every 2 weeks. It acts by binding SV2A receptors."
Budesonide
| Indication | Form Used |
|---|---|
| Asthma - maintenance/prophylaxis | Nebulizer / DPI inhaler |
| Croup | Nebulized (acute treatment) |
| Allergic rhinitis | Nasal spray |
| Crohn's disease | Oral capsule |
| Ulcerative colitis | Oral/rectal |
| Age | Previous Therapy | Dose |
|---|---|---|
| Child 1-8 yr | No prior steroids | 0.5 mg/24 hr once daily-BID (max 0.5 mg/24 hr) |
| Child 1-8 yr | Prior inhaled steroids | 0.5 mg/24 hr once daily-BID (max 1 mg/24 hr) |
| Child 1-8 yr | Prior oral steroids | 1 mg/24 hr once daily-BID (max 1 mg/24 hr) |
| Age | Low | Medium | High |
|---|---|---|---|
| 0-4 yr | 0.25-0.5 mg/24 hr | 0.5-1 mg/24 hr | >1 mg/24 hr |
| 5-11 yr | 0.5 mg/24 hr | 1 mg/24 hr | 2 mg/24 hr |
| Age | Dose |
|---|---|
| Child ≥6 yr | Start 180 mcg BID, max 360 mcg BID |
| Adult | Start 360 mcg BID, max 720 mcg BID |
| Form | Brand | Use |
|---|---|---|
| Nebulizer suspension | Pulmicort Respules | Asthma <8 yr, Croup |
| DPI inhaler | Pulmicort Flexhaler | Asthma ≥6 yr |
| Nasal spray | Rhinocort | Allergic rhinitis |
| Oral capsule | Entocort EC | Crohn's disease |
| Oral tablet | Uceris | Ulcerative colitis |
Piperaciline and tazobactam
| Indication | Notes |
|---|---|
| Severe nosocomial infections | Hospital-acquired pneumonia |
| Intra-abdominal infections | Appendicitis, peritonitis |
| Sepsis | Broad-spectrum empiric coverage |
| Complicated UTI / Pyelonephritis | |
| Skin & soft tissue infections | |
| Febrile neutropenia | Empiric therapy |
| Cystic fibrosis | Antipseudomonal |
| Polymicrobial infections | Anaerobes + gram-negatives |
| Weight/Age | Dose |
|---|---|
| ≤2 kg, ≤7 days | 100 mg/kg/dose Q8 hr |
| ≤2 kg, 8-28 days (≤30 wk PMA) | 100 mg/kg/dose Q8 hr |
| ≤2 kg, 8-28 days (>30 wk PMA) | 80 mg/kg/dose Q6 hr |
| >2 kg, ≤60 days | 80 mg/kg/dose Q6 hr |
| Indication | Age | Dose | Frequency |
|---|---|---|---|
| Severe infections / Pneumonia | 2-9 mo | 80 mg/kg/dose IV | Q6 hr |
| Severe infections / Pneumonia | >9 mo - adolescent | 100 mg/kg/dose IV (max 4000 mg) | Q6 hr |
| Appendicitis / Peritonitis | 2-9 mo | 80 mg/kg/dose IV | Q8 hr |
| Appendicitis / Peritonitis | >9 mo, ≤40 kg | 100 mg/kg/dose IV (max 3000 mg) | Q8 hr |
| Appendicitis / Peritonitis | >9 mo, >40 kg | 3 g/dose IV | Q6 hr |
| Cystic fibrosis (antipseudomonal) | All ages | 350-600 mg/kg/24 hr | ÷ Q4-6 hr |
"Pip-Tazo covers PANS" Pseudomonas, Anaerobes, Normal gram-negatives, Staph (MSSA only)
Amoxiclav
| Indication | Dose (amoxicillin component) | Frequency |
|---|---|---|
| Standard (child <40 kg) | 20-40 mg/kg/24 hr | ÷ Q8 hr (TID) |
| Standard BID | 25-45 mg/kg/24 hr | ÷ Q12 hr |
| High dose (severe/resistant) | 90 mg/kg/24 hr (ES-600) | ÷ Q8-12 hr |
| Infant 1-3 months | 30 mg/kg/24 hr | ÷ Q12 hr |
Ceftriaxone
| Indication | Notes |
|---|---|
| Bacterial Meningitis | Most important pediatric use |
| Severe/complicated infections | Sepsis, pneumonia |
| Typhoid fever | Drug of choice in children |
| Acute Otitis Media (AOM) | Single IM dose option |
| Gonorrhea / PID | STI treatment |
| Lyme disease | IV for CNS involvement |
| Endocarditis prophylaxis | Dental/respiratory procedures |
| Neonatal gonococcal ophthalmia | Prophylaxis + treatment |
| Indication | Dose | Frequency |
|---|---|---|
| Mild/moderate infections | 50-75 mg/kg/24 hr (max 2 g/24 hr) | ÷ Q12-24 hr |
| Severe infections / Meningitis | 100 mg/kg/24 hr (max 2 g/dose, 4 g/24 hr) | ÷ Q12 hr |
| Penicillin-resistant pneumococcus | 80-100 mg/kg/24 hr (max 4 g/24 hr) | ÷ Q12-24 hr |
| Acute Otitis Media | 50 mg/kg IM/IV x 1 (max 1 g) | Single dose |
| Lyme disease | 50-75 mg/kg/dose (max 2 g) IV | Once daily |
| Neonatal gonococcal | 25-50 mg/kg/dose (max 250 mg) IM/IV | x 1 dose |
| Endocarditis prophylaxis | 50 mg/kg IV/IM (max 1 g) | 30-60 min before procedure |
"50 for mild, 100 for meningitis" 50-75 mg/kg/24 hr → mild/moderate 100 mg/kg/24 hr → severe/meningitis
Make table of all the drug their main 2- 3 indications , type ,and mechanism in very very short no need for doses and make pdf also
Pediatrics Drug Summary
PDF Document · PDF
| Drug | Type | Mechanism | Main Indications |
|---|---|---|---|
| Neostigmine | Anticholinesterase | Inhibits AChE → ↑ACh | MG, NMB reversal, OP poisoning |
| Paracetamol | Analgesic/Antipyretic | COX inhibition (central) | Fever, Pain, PDA |
| Adrenaline | Catecholamine (α,β agonist) | Stimulates adrenergic receptors | Anaphylaxis, Cardiac arrest, Croup |
| Atropine | Anticholinergic | Blocks muscarinic receptors | Bradycardia, OP poisoning, Pre-intubation |
| Ondansetron | 5-HT3 antagonist | Blocks serotonin in gut/CTZ | CINV, Gastroenteritis, PONV |
| Dopamine | Sympathomimetic | D1→β1→α1 (dose-dependent) | Shock, Low CO, Bradycardia |
| Vitamin K1 | Fat-soluble vitamin | Activates clotting factors II,VII,IX,X | HDN, Warfarin reversal, Deficiency |
| Phentolamine | α-blocker (non-selective) | Blocks α1+α2 → vasodilation | Phaeochromocytoma, HTN crisis, Extravasation |
| Dexamethasone | Glucocorticoid | Inhibits phospholipase A2 → ↓PGs | Croup, Meningitis, Asthma |
| Artesunate | Artemisinin antimalarial | →DHA→free radicals→kills Plasmodium | Severe malaria, Cerebral malaria, MDR malaria |
| Metronidazole | Nitroimidazole | Toxic radicals damage DNA (anaerobes) | Amoebiasis, Giardiasis, Anaerobic infections |
| Cefpodoxime | 3rd gen cephalosporin (oral) | Beta-lactam → inhibits PBPs | AOM, Pharyngitis, UTI |
| Amoxiclav | Aminopenicillin + BLI | Cell wall inhibition + β-lactamase block | AOM, Bites (DOC), CAP |
| Levetiracetam | AED | Binds SV2A → ↓neurotransmitter release | Partial seizures, Tonic-clonic, Status epilepticus |
| Budesonide | Inhaled corticosteroid | ↓airway inflammation locally | Asthma (maintenance), Croup, Allergic rhinitis |
| Pip-Tazo | Extended-spectrum penicillin + BLI | Cell wall + β-lactamase inhibition | Nosocomial infections, Neutropenic fever, Pseudomonas |
| Ceftriaxone | 3rd gen cephalosporin (IV/IM) | Beta-lactam → inhibits PBPs | Meningitis, Typhoid, Sepsis |
Zinc gluconate
| Indication | Notes |
|---|---|
| Zinc Deficiency | Malnutrition, malabsorption |
| Acute Diarrhoea in children | WHO recommendation - reduces severity & duration |
| Wilson's Disease | Blocks copper absorption |
| Acrodermatitis enteropathica | Inherited zinc deficiency |
| Parenteral nutrition supplementation | TPN |
| Burns / Excessive losses | Replacement |
| Age | Dose | Duration |
|---|---|---|
| <6 months | 10 mg/day | 10-14 days |
| ≥6 months | 20 mg/day | 10-14 days |
"Zinc 20 mg/day x 14 days along with ORS is the WHO-recommended adjunct therapy for acute diarrhoea in children ≥6 months - it reduces duration, severity and risk of recurrence."
Biors withe pre and pro biotics
Biors is a brand name combining digestive enzymes + prebiotics + probiotics (synbiotic product). For viva, you need to know the concepts well.
| Term | Definition | Example |
|---|---|---|
| Probiotic | Live microorganisms that, when given in adequate amounts, confer health benefit on the host | Lactobacillus, Bifidobacterium, Saccharomyces |
| Prebiotic | Non-digestible food ingredient that selectively stimulates growth/activity of beneficial gut bacteria | FOS, GOS, Inulin, Lactulose |
| Synbiotic | Combination of probiotic + prebiotic together | Biors, Enterogermina + FOS |
| Postbiotic | Metabolic byproducts of probiotics that benefit the host | SCFAs, bacteriocins |
| Organism | Notes |
|---|---|
| Lactobacillus rhamnosus GG (LGG) | Most evidence-based; best studied |
| Lactobacillus reuteri DSM 17938 | Infant colic, diarrhoea |
| Bifidobacterium lactis | Common in infant formulas |
| Saccharomyces boulardii | Yeast; antibiotic-associated diarrhoea |
| Streptococcus thermophilus | Yogurt organism |
| Indication | Evidence | Notes |
|---|---|---|
| Acute Infectious Diarrhoea | ✅ Good | Reduces duration ~1 day; LGG and S. boulardii best evidence |
| Antibiotic-Associated Diarrhoea | ✅ Good | Give probiotic with antibiotic course |
| C. difficile Prevention | ✅ Moderate | S. boulardii + LGG |
| Infant Colic | ✅ Moderate | L. reuteri DSM 17938 in breastfed infants |
| Necrotizing Enterocolitis (NEC) prevention | ✅ Good | In preterm neonates |
| Constipation | ✅ Some evidence | L. reuteri, B. lactis |
| Atopic dermatitis prevention | ✅ Some evidence | Prenatal + postnatal use |
| IBD maintenance | ✅ Ulcerative colitis | VSL#3 combination |
| Irritable Bowel Syndrome | ✅ Moderate |
| Product | Dose |
|---|---|
| LGG (Culturelle) | 10 billion CFU once or twice daily |
| S. boulardii (Florastor) | 250-500 mg BID |
| L. reuteri drops | 5 drops (10⁸ CFU) once daily (infant colic) |
| VSL#3 | 1 sachet/day (child) |
| Prebiotic | Source | Function |
|---|---|---|
| FOS (Fructooligosaccharides) | Onion, garlic, banana | Feeds Bifidobacteria in colon |
| GOS (Galactooligosaccharides) | Human breast milk | Promotes Bifidobacterium growth |
| Inulin | Chicory root | Bifidogenic effect |
| Lactulose | Synthetic | Prebiotic + laxative |
Breast milk is the best natural prebiotic - contains HMOs (Human Milk Oligosaccharides)
"Probiotics are live microorganisms that restore gut flora; prebiotics are non-digestible substrates that feed them. Together (synbiotics), they are used in pediatrics mainly for acute diarrhoea, antibiotic-associated diarrhoea, infant colic, and NEC prevention in preterm neonates."